DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo


15.26 -0.65 (-4.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

INSM $15.26 -4.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.03
Previous Close $15.91
Daily Range $15.06 - $16.06
52-Week Range $11.25 - $21.15
Market Cap $757.9M
P/E Ratio -8.33
Dividend (Yield) $0.00 (0.0%)
Volume 342,038
Average Daily Volume 521,633
Current FY EPS -$2.07





INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape

Markets Rise; Macy's Lowers Comparable Sales Outlook

Markets Rise; Macy's Lowers Comparable Sales Outlook

Benzinga's Volume Movers

Sector Update: Health Care

See More INSM News...

INSM's Top Competitors

INSM $15.26 (-4.09%)
Current stock: INSM
AMGN $154.64 (-2.67%)
Current stock: AMGN
GILD $102.45 (-2.46%)
Current stock: GILD
BIIB $351.18 (-1.87%)
Current stock: BIIB